A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2006
10/11/2006	EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists
10/11/2006	EP1469851B1 Melanocortin receptor agonists
10/11/2006	EP1469741B1 A process for the extraction,purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
10/11/2006	EP1432730A4 Glucagon-like peptide-1 analogs
10/11/2006	EP1399150A4 Vitamin c compositions
10/11/2006	EP1216232B1 Heterocyclic compounds and methods for modulating cxcr3 function
10/11/2006	EP0982990B1 Stable liquid calcium ascorbate compositions and methods of manufacture and use
10/11/2006	EP0954565B1 Adipogenic differentiation of human mesenchymal stem cells
10/11/2006	EP0894000B1 Use for delivering estrogen
10/11/2006	EP0832225B1 Chimeric proteins for use in transport of a selected substance into cells
10/11/2006	EP0804479B1 Method of treating diabetes mellitus using kgf
10/11/2006	CN1846456A Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone
10/11/2006	CN1845916A 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
10/11/2006	CN1845749A Use of a single-cell protein material
10/11/2006	CN1845748A Fish protein hydrolyzate
10/11/2006	CN1845735A Novel medical use of selective cb1-receptor antagonists
10/11/2006	CN1845731A Combination therapy for glycaemic control
10/11/2006	CN1844925A Method for determining bioactivity of recombinant insulin secretagogue and application thereof
10/11/2006	CN1844164A Process for preparing carboxymethyl chitosan calcium and application thereof
10/11/2006	CN1844137A Preparation process of chromium glucosaminic acid and use thereof
10/11/2006	CN1844096A Preparation of mitiglinide calcium and its quality control method
10/11/2006	CN1843475A Traditional Chinese Medicinal formulation for treating diabetes and preparation method thereof
10/11/2006	CN1843460A Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method
10/11/2006	CN1843449A Chinese proprietary medicine for treating advanced stage rachitis
10/11/2006	CN1843408A Fat-reducing ointment for burning fat
10/11/2006	CN1843406A Blood fat-reducing medicine and its preparation method
10/11/2006	CN1843403A Red salvia root and ligustrazine transfusion liquid and its preparation process
10/11/2006	CN1843385A Enteral microecological formulation and its preparation process
10/11/2006	CN1843376A Method for extracting and purifying calf serum protein-removing extract
10/11/2006	CN1843374A Traditional Chinese and western style oral composite nutrient formulation for treating type 2 diabetes
10/11/2006	CN1843365A Use of polyene phosphatidylcholine in preparing medicine for treating fat thrombus
10/11/2006	CN1843357A Pharmaceutical compositions of levoamlodipine and atorvastatin
10/11/2006	CN1843352A Mitiglinide calcium formulation formula
10/11/2006	CN1843330A Slow release agent containing aminoglycosides antibiotic and its uses
10/11/2006	CN1843142A Snow lotus fruit soaked tea and its preparation process
10/11/2006	CN1279054C Type I cytokine receptor TCCR
10/11/2006	CN1279040C Tryasolyl tropane derivatives for therapy
10/11/2006	CN1278737C Compound medicinal formulation with bioactivity
10/11/2006	CN1278725C Transfusion containing gen-seng, lilyturf root, Chinese magnoliavine fruit and amino acid and its production method
10/11/2006	CN1278723C Chinese medicine prescription for treating diabetes retina pathologic change
10/11/2006	CN1278721C Compound preparation of shaping body by consuming fat and its preparing method
10/11/2006	CN1278715C Medication for treating diabetes
10/11/2006	CN1278704C Health products for assisting in reducing blood sugar and blood fat and its production method
10/11/2006	CN1278701C Transfusion of astragalus root amino acid and its preparing method
10/11/2006	CN1278692C Great burnet polysaccharide formulation, and its preparation method and use
10/11/2006	CN1278690C 25-hydroxy vitamin D3 compositions
10/11/2006	CN1278682C Nanometer preparation of natural vitamin E
10/11/2006	CN1278678C Pharmaceutical composition of fenofibrate with high biological utilizing rate and its preparation method
10/11/2006	CN1278677C Composition for improving lipid metabolism
10/11/2006	CN1278620C Salty sweets
10/10/2006	US7119221 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders
10/10/2006	US7119201 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/10/2006	US7119170 Administering a polypeptide; blood disorders
10/10/2006	US7119120 A 2-benzenesulfonylamino-N-benzyl-benzamides for treating hyperphosphatemia, urogential disorders
10/10/2006	US7119117 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/10/2006	US7119110 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
10/10/2006	US7119107 Pyridone derivatives
10/10/2006	US7119104 Alpha-(oxy-, sulfo- or amino-)[3-(imidazolyl, oxazolyl or thiazolyl)alkylene(indazolyl, benzisoxazolyl or benzisothiazolyl)]acetic acids, esters or alkali salts
10/10/2006	US7119103 β3-Adrenoreceptor agonists, agonist compositions and methods of using
10/10/2006	US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases
10/10/2006	US7119090 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases, enzyme inhibitors
10/10/2006	US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis
10/10/2006	US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
10/10/2006	US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
10/10/2006	US7119066 Replacing cysteine 17 with alanine, glutamine 63 with arginine and a deletion of the terminal 15 amino acid residues; treatment of huntington's disease, obesity, and gestational or adult onset diabetes
10/10/2006	US7118903 Comprises genetically engineered protein for use in treatment and prevention of cancer, obesity, cardiac, vascular, neurologic and or aging disorders
10/10/2006	US7118873 Polynucleotides encoding cellular transporters and methods of use thereof
10/10/2006	US7118856 Enzyme catalyst; polypeptides; crystal structure
10/10/2006	US7118762 Controlling, stabilization blood, glucose concentration
10/10/2006	US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA
10/10/2006	CA2418778C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/10/2006	CA2352554C Substituted benzimidazoles and their use as parp inhibitors
10/10/2006	CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
10/10/2006	CA2321909C Product and method to reduce stress induced immune suppression
10/10/2006	CA2262778C Conformationally constrained backbone cyclized somatostatin analogs
10/10/2006	CA2255951C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
10/10/2006	CA2253407C Inorganic ion receptor-active compounds
10/10/2006	CA2231292C Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
10/10/2006	CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
10/10/2006	CA2113623C Use of quinolizine derivatives as orexigenics
10/05/2006	WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors
10/05/2006	WO2006105023A1 Pyridine derivatives useful as inhibitors of pkc-theta
10/05/2006	WO2006104399A1 Copper antagonist compositions
10/05/2006	WO2006104398A1 Copper antagonist compositions
10/05/2006	WO2006104397A1 Copper antagonist compositions
10/05/2006	WO2006104396A1 Pre-complexed copper antagonist compositions
10/05/2006	WO2006104280A1 Prophylactic/therapeutic agent for diabetes
10/05/2006	WO2006104137A1 Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same
10/05/2006	WO2006104030A1 Thiazole compound
10/05/2006	WO2006103895A1 Appetite-suppressing agent and air-conditioning apparatus for dieting
10/05/2006	WO2006103750A1 Composition, functional food and pharmaceutical composition for improvement in obesity
10/05/2006	WO2006103690A1 A novel process for preparation of substantially pure glimepiride
10/05/2006	WO2006103511A1 Cyclopentapyridine and tetrahydroquinoline derivatives
10/05/2006	WO2006103342A2 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
10/05/2006	WO2006102804A1 The compound preparation for treating diabetes mellitus
10/05/2006	WO2006102788A1 The complex antihyperlipidemics
10/05/2006	WO2006102752A1 Compositions for oral transmucosal delivery of metformin
10/05/2006	WO2006076595A8 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
10/05/2006	WO2006055511A3 Stable tablet formulation of tetrahydrobiopterin
10/05/2006	WO2006048330A8 11βετα-hsd1 inhibitors

1 ... 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 ... 1298